Comparison

Oritinib European Partner

Item no. TMO-T60076-100mg
Manufacturer TargetMol
CASRN 2035089-28-0
Amount 100mg
Category
Type Inhibitor
Specific against other
Purity 0,98
Smiles O=C(C=C)NC1=CC(NC=2N=CC=C(N2)C=3C=4C=CC=CC4N5C3CCCC5)=C(OC)C=C1N(C)CCN(C)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias SH-1028
Available
Short Description
Oritinib is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and 0.89 nM for EGFR (wt), EGFR (L858R), EGFR (L861Q), EGFR (L858R/T790M), EGFR (d746-750), EGFR (d746-750/T790M), respectively. Oritinib can be used in studies about the treatment of non-small cell lung cancer.
Shipping
cool pack
Storage
-20°
Target names or alias
SH-1028
Molecular Weight
539, 67
Pathway
JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors
Target
EGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close